"Following CDC recommendations, anyone entering this facility must wear a mask. If you do not have one, we will provide you with a mask if necessary and available. The pharmacy and lab departments at Honolulu Medical Office are currently closed on Saturdays. In-person pharmacy and lab services are still available on the weekends at the following locations. Waipio Medical Office: Pharmacy-Saturday, 8 a.m. to noon, Lab-Saturday, 7:30 a.m. to noon; Moanalua Medical Center: Pharmacy-24 hours a day, 7 days a week, Lab-Saturday, 7:30 a.m. to noon. Our farmers markets are cancelled until further notice. Mahalo for your cooperation and understanding."

During the past decade, Kaiser Permanente- Hawaii conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente- Hawaii" #1 sponsor was "Karyopharm Therapeutics Inc" with 2 trials, followed by "W.L.Gore & Associates" with 2 trials sponsored, "AVEO Pharmaceuticals, Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Kaiser Permanente" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente- Hawaii" #1 collaborator was "Columbia University" with 2 trials as a collaborator, "Kaiser Permanente" with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator, "Biodesix, Inc." with 1 trials as a collaborator and "Centers for Medicare and Medicaid Services" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente- Hawaii" are "Carotid Artery Disease" (2 trials), "Multiple Myeloma" (2 trials), "Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Carotid Artery Stenosis" (1 trials). Many other conditions were trialed in "Kaiser Permanente- Hawaii" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente- Hawaii" are "Drug" (9 trials), "Device" (4 trials), "Biological" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Selinexor" (2 trials), "Azithromycin" (1 trials), "BARD LifeStent" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente- Hawaii" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente- Hawaii". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Kaiser Permanente- Hawaii, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente- Hawaii, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".